SEC Form 4 · accession 0001209191-16-102034
Endo International plc · ENDP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Lortie
Officer — President Branded Pharma
Period of report
Feb 22, 2016
Accepted (ET)
Feb 24, 2016 · 5:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001593034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2,F3 | Feb 22, 2016 | F | 305 | $50.70 | D | 18,010 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Twenty-five percent (25%) of Mr. Lortie's February 22, 2012 grant of restricted stock units (RSUs) vested on February 22, 2016. Upon vesting, certain shares were withheld by the issuer to satisfy tax obligations on shares acquired.
- F2These shares represent stock withheld by the issuer to satisfy tax withholding obligations on shares acquired upon vesting of RSUs.
- F3$50.70 represents the vesting price, which is the average of the high and low share price on February 22, 2016.